Armando Anido
2016
In 2016, Armando Anido earned a total compensation of $901.2K as Chairman of the Board and Chief Executive Officer at Zynerba Pharmaceuticals, a 81% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $337,428 |
---|---|
Salary | $535,600 |
Other | $28,179 |
Total | $901,207 |
Anido received $535.6K in salary, accounting for 59% of the total pay in 2016.
Anido also received $337.4K in non-equity incentive plan and $28.2K in other compensation.
Rankings
In 2016, Armando Anido's compensation ranked 8,740th out of 14,075 executives tracked by ExecPay. In other words, Anido earned more than 37.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,740 | 38th |
Manufacturing | 3,375 | 39th |
Chemicals And Allied Products | 1,148 | 39th |
Drugs | 901 | 41st |
Pharmaceutical Preparations | 718 | 39th |
Anido's colleagues
We found two more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2016.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019